MUMBAI, India, July 7, 2026 /PRNewswire/ — Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global platform, investing in…
Source: prnewswire
Country: United States